Full description
Data for 372 adult patients with advanced non-small cell lung cancer. Treatment regime was standard chemotherapy with (n=185) or without (n=187) application of a nitroglycerin 25 mg patch. Study assessments were carried out at baseline before randomization, then every 3 weeks during chemotherapy, and every 4 weeks from completion of chemotherapy until disease progression. Dataset includes: Progression free survival, overall survival data, demographic data, diagnostic data, treatment data, quality of life data, objective tumour response. (RECIST 1.1), adverse events.Notes
HeSANDA 1.0.0Issued: 2023
Other Information
Cancer Council Western Australia
ROR :
https://ror.org/0184qmt78
Cancer Council Queensland
ROR :
https://ror.org/03g5d6c96
Cancer Council New South Wales
ROR :
https://ror.org/05gsbkp40
National Health and Medical Research Council
Identifiers
- DOI : 10.58106/914N-JZ74